≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of nasopharynx, including Hilmo

Endpoint Browser PheWeb

C3_NASOPHARYNX_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C11
  • Hospital discharge: ICD-9 — 147
  • Hospital discharge: ICD-8 — 147
  • Cause of death: ICD-10 — C11
  • Cause of death: ICD-9 — 147
  • Cause of death: ICD-8 — 147
  • Cancer registry: Topography ICD-O-3 — C11
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

170

4. Check minimum number of events

None

170

5. Include endpoints

None

170

6. Filter based on genotype QC (FinnGen only)

158

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 158 62 96
Unadjusted period prevalence (%) 0.04 0.02 0.04
Median age at first event (years) 62.05 59.00 64.01

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
170
Matched controls
1700
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
93.6
81
*
A03FA01
ATC
metoclopramide; systemic, rectal
20.0
89.8
97
106
C11.9
ICD-10 Finland
Malignant neoplasm: Nasopharynx, unspecified
+∞
80.8
71
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
19.6
75.4
71
60
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
424.7
60.4
57
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
57.6
52
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
715.1
54.8
51
*
H02AB02
ATC
dexamethasone; systemic
80.3
42.9
47
8
XX3DW
NOMESCO Finland
Time consuming IT work
14.7
41.2
41
36
C11.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of nasopharynx
+∞
40.2
37
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
40.2
37
*
8070/3-C11.9
ICD-O-3
Squamous cell carcinoma, NOS, of nasopharynx, NOS
+∞
37.9
35
*
WZC00
NOMESCO Finland
Treatment plan or consultation
7.2
37.7
96
259
N02AA05
ATC
oxycodone; systemic
7.6
35.9
69
140
A04AA02
ATC
granisetron; systemic, transdermal
+∞
35.7
33
*
A04AA01
ATC
ondansetron; systemic, rectal
36.8
31.6
40
14
UDQ12
NOMESCO Finland
Flexible laryngoscopy
10.0
30.3
39
49
C11.0
ICD-10 Finland
Malignant neoplasm: Superior wall of nasopharynx
+∞
26.8
25
*
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
159.3
26.4
27
*
A07AA02
ATC
nystatin; oral
9.3
26.1
35
46
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
291.0
25.4
25
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
24.6
23
*
C11.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of nasopharynx
+∞
23.5
22
*
C11.1
ICD-10 Finland
Malignant neoplasm: Posterior wall of nasopharynx
+∞
23.5
22
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
138.8
23.2
24
*
EBA10
NOMESCO Finland
Operative extraction of tooth
6.7
22.7
42
79
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
33.1
21.8
28
10
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
21.3
20
*
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
87.8
21.3
23
*
SCA02
NOMESCO Finland
Preventive oral health care
7.1
21.1
36
62
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
31.7
20.8
27
10
R13
ICD-10 Finland
Dysphagia
7.0
20.2
35
61
H65.2
ICD-10 Finland
Chronic serous otitis media
46.1
20.1
24
6
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
18.9
19.7
30
19
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
9.3
19.3
25
31
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
19.1
18
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
19.1
18
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.7
17.2
49
134
A04AA55
ATC
palonosetron, combinations; systemic
+∞
17.0
16
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
17.0
16
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
100.1
16.9
18
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
23.9
16.5
23
11
L03AA13
ATC
pegfilgrastim; parenteral
175.5
15.8
16
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.8
15.3
41
106
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
62.5
15.1
17
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
12.1
14.9
27
26
SXB00
NOMESCO Finland
Removal of sutures from oral mucosa
6.4
14.8
27
49
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
14.8
14
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
163.5
14.7
15
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
151.6
13.7
14
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
18.7
13.4
20
12
SBB10
NOMESCO Finland
Dental impressions
6.9
13.3
22
36
EBA15
NOMESCO Finland
Extraction of multiple teeth
12.0
13.3
24
23
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
54.4
13.1
15
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
12.7
12
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
12.7
12
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
+∞
12.7
12
*
K11.70
ICD-10 Finland
Hypoptyalism
+∞
12.7
12
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
12.7
12
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.1
12.1
86
419
H65.3
ICD-10 Finland
Chronic mucoid otitis media
15.1
11.8
19
14
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
13.2
11.7
20
17
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
11.6
11
*
A04AD12
ATC
aprepitant; systemic
+∞
11.6
11
*
L03AA02
ATC
filgrastim; parenteral
+∞
11.6
11
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
11.6
11
*
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
+∞
11.6
11
*
JN4BD
NOMESCO Finland
Extensive body CT
6.2
11.5
21
38
WZC30
NOMESCO Finland
Teaching
4.2
11.5
35
99
C61
ICD-10 Finland
Malignant neoplasm of prostate
116.9
10.5
11
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
10.5
10
*
ENA10
NOMESCO Finland
Biopsy of pharynx
+∞
10.5
10
*
8010/3-C11.9
ICD-O-3
Carcinoma, NOS, of nasopharynx, NOS
+∞
10.5
10
*
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
25.2
10.4
14
6
UDM02
NOMESCO Finland
Sinoscopy
15.9
10.2
16
11
H66.0
ICD-10 Finland
Acute suppurative otitis media
5.1
10.1
23
51
WX199
NOMESCO Finland
Other local analgesia
9.7
10.1
20
23
H66.9
ICD-10 Finland
Otitis media, unspecified
9.6
9.6
19
22
C09.0
ICD-10 Finland
Malignant neoplasm: Tonsillar fossa
+∞
9.5
9
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
9.5
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
9.5
9
*
9680/3-C11.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS
+∞
9.5
9
*
SAA03
NOMESCO Finland
Extended examination of mouth
2.8
9.4
76
385
R4190
NOMESCO Finland
Nutritional therapy
12.5
9.3
16
14
A01AB09
ATC
miconazole; local oral
4.0
9.1
28
79
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
19.9
9.1
13
7
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.8
9.0
31
95
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
7.3
9.0
21
32
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.1
8.8
26
71
DHA10
NOMESCO Finland
Biopsy of cavity of nose
13.7
8.5
14
11
D70.82
ICD-10 Finland
Drug-induced neutropenia
94.6
8.5
9
*
EMB10
NOMESCO Finland
Tonsillectomy
11.6
8.5
15
14
Z51.5
ICD-10 Finland
Palliative care
8.3
8.4
18
24
8072/3-C11.9
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of nasopharynx, NOS
+∞
8.4
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.4
8
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
8.4
8
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
8.4
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
10.8
8.2
15
15
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
23.4
8.1
11
5
A06AD11
ATC
lactulose; oral
3.1
8.1
40
154
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
7.6
8.0
18
26
UJC01
NOMESCO Finland
Scopy of lower throat
16.0
7.8
12
8
DFF00
NOMESCO Finland
Pure tone audiometry
3.4
7.8
31
104
H03AA01
ATC
levothyroxine sodium; systemic
2.8
7.7
49
216
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.6
7.6
59
288
UDC00
NOMESCO Finland
Ear microscopy
3.7
7.6
26
79
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
7.6
49
218
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
9.0
7.5
15
18
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
9.0
7.5
15
18
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.6
7.4
56
269
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
8070/3-C11.2
ICD-O-3
Squamous cell carcinoma, NOS, of lateral wall of nasopharynx
+∞
7.3
7
*
8070/3-C09.9
ICD-O-3
Squamous cell carcinoma, NOS, of tonsil, NOS
+∞
7.3
7
*
8070/3-C11.1
ICD-O-3
Squamous cell carcinoma, NOS, of posterior wall of nasopharynx
+∞
7.3
7
*
116
Kela drug reimbursment
Prostate cancer
+∞
7.3
7
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
31.5
7.2
9
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.8
7.1
23
67
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
17.6
6.8
10
6
PJA10
NOMESCO Finland
Exploration of lymph nodes
41.8
6.8
8
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
6.8
43
189
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
72.5
6.5
7
*
JN4AD
NOMESCO Finland
Body CT examination
4.3
6.3
17
43
SXC03
NOMESCO Finland
Other oral or dental procedure
18.9
6.3
9
5
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
+∞
6.3
6
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
6.3
6
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
6.3
6
*
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
8.2
6.2
13
17

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
45
31
19.38
52.21
1.5
1.3
—
—
—
0
0
58
173
4.57
18.34
6.7
2.4
0.77
0.83
mmol/l
4.70
53
159
78
347
3.31
13.06
2.9
1.5
—
—
—
0
0
43
142
3.71
11.34
2.1
1.8
—
—
—
0
0
95
532
2.78
9.78
6.6
5.4
0.67
0.69
%
0.08
88
496
111
675
2.86
9.70
15.0
6.1
3.95
4.29
e9/l
0.88
97
596
96
556
2.67
9.02
6.7
5.3
2.89
3.05
%
0.26
88
519
96
558
2.66
8.92
7.0
5.6
8.94
8.55
%
0.58
89
520
96
571
2.57
8.32
7.0
5.4
26.56
27.61
%
0.28
90
535
66
333
2.61
8.02
2.3
1.9
—
—
—
0
0
94
568
2.46
7.68
6.7
5.2
58.52
57.21
%
0.42
88
535
97
595
2.47
7.66
6.5
5.0
0.59
0.59
e9/l
0.03
82
520
97
596
2.46
7.62
6.6
5.1
0.04
0.04
e9/l
0.89
82
527
87
512
2.43
7.48
5.7
3.1
34.17
35.50
g/l
1.15
80
479
91
547
2.43
7.46
7.1
5.6
—
—
—
0
0
98
612
2.42
7.33
6.7
5.2
0.17
0.20
e9/l
1.17
83
543
97
606
2.40
7.21
6.7
5.2
1.62
1.85
e9/l
1.63
86
539
63
333
2.42
6.74
3.6
3.8
—
—
—
0
0
42
185
2.69
6.56
1.8
1.8
—
—
—
0
0
68
382
2.30
6.25
4.9
2.0
2.36
2.35
mmol/l
0.10
60
327
24
79
3.37
6.21
1.7
1.1
—
—
—
0
0
18
55
3.54
5.19
1.3
1.5
—
—
—
0
0
90
609
2.02
4.80
8.8
5.3
1.22
1.22
mmol/l
0.00
81
528
24
95
2.78
4.53
1.2
1.6
—
—
—
0
0
80
531
1.96
4.40
7.4
5.0
1.22
1.21
mmol/l
0.63
75
472
25
104
2.65
4.30
1.4
1.3
—
—
—
0
0
9
13
7.24
4.22
1.2
1.1
—
—
—
0
0
31
152
2.27
3.76
3.5
4.6
1.01
0.98
mmol/l
0.24
26
141
27
127
2.34
3.59
1.4
1.7
—
—
—
0
0
25
114
2.40
3.56
2.2
1.6
396.28
362.27
nmol/l
0.42
25
100
88
635
1.80
3.49
15.0
15.4
1.45
1.35
inr
0.27
21
184
29
147
2.17
3.24
1.8
1.4
—
—
—
0
0
24
116
2.24
3.00
4.3
3.1
—
—
—
0
0
6
9
6.86
2.89
1.2
1.2
—
—
—
0
0
20
91
2.36
2.87
5.1
4.8
1.15
0.82
%
0.36
13
31
120
980
1.76
2.84
11.8
5.0
79.49
77.27
u/l
0.23
115
899
109
1284
0.58
2.81
4.3
4.2
1.31
1.32
mmol/l
0.05
100
1173
18
79
2.43
2.79
2.7
5.2
0.73
0.26
%
1.27
11
23
44
273
1.83
2.78
11.0
4.2
—
—
—
0
0
30
498
0.52
2.75
3.1
3.2
—
—
—
0
0
8
19
4.36
2.71
1.3
1.3
—
—
—
0
0
120
1374
0.57
2.68
5.2
5.3
2.75
2.67
mmol/l
0.32
110
1268
9
25
3.74
2.61
1.2
1.1
—
—
—
0
0
115
1328
0.59
2.58
4.8
4.7
1.38
1.43
mmol/l
0.84
107
1226
110
1280
0.60
2.46
5.9
6.4
40.31
40.74
mmol/mol
0.19
100
1199
18
85
2.25
2.39
5.5
5.0
0.00
0.12
%
1.08
11
25
17
79
2.28
2.34
1.4
1.2
—
—
—
0
0
6
13
4.74
2.29
2.7
1.2
—
—
—
0
0
118
1338
0.61
2.14
4.7
4.7
4.60
4.56
mmol/l
0.11
110
1243
7
21
3.43
1.98
1.9
3.0
—
—
—
0
0
12
54
2.32
1.78
19.6
8.7
—
—
—
0
0
111
948
1.49
1.68
4.9
3.9
15.23
11.65
mm/h
1.44
104
866
119
1326
0.66
1.64
5.0
4.7
6.06
6.09
mmol/l
0.08
109
1203
31
203
1.64
1.60
2.6
2.8
2.43
1.98
e6/l
0.18
19
108
27
172
1.68
1.55
1.1
1.2
—
—
—
0
0
48
352
1.51
1.54
4.5
3.0
7.39
7.40
ph
—
7
57
41
293
1.53
1.48
1.5
1.3
—
—
—
0
0
41
295
1.51
1.43
4.4
3.9
311.70
267.15
ng/l
0.05
35
249
5
124
0.39
1.43
2.4
1.5
—
—
—
0
0
47
349
1.48
1.41
3.4
2.4
348.27
11858.27
umol/l
2.76
40
304
5
19
2.68
1.22
1.4
1.2
—
—
—
0
0
14
80
1.82
1.17
6.4
5.0
0.00
0.00
%
—
8
20
9
46
2.01
1.05
2.4
2.0
—
—
—
0
0
5
22
2.31
1.04
2.0
1.2
48.60
13.27
u/ml
—
5
22
9
48
1.92
1.02
6.3
4.0
—
—
—
0
0
64
537
1.31
0.90
10.3
7.9
0.00
0.00
e9/l
-0.00
46
442
45
363
1.33
0.83
3.3
2.9
—
—
—
0
0
5
97
0.50
0.81
3.0
2.8
—
—
—
0
0
0
27
0.00
0.78
0.0
1.9
—
—
—
0
0
14
206
0.65
0.77
1.1
1.3
10.28
29.59
iu/ml
—
6
67
87
962
0.80
0.69
3.8
3.9
—
—
—
0
0
54
627
0.80
0.67
5.3
3.7
2.45
1.96
ug/l
0.60
48
556
7
44
1.62
0.66
4.4
1.7
—
—
—
0
0
28
351
0.76
0.63
2.4
2.5
0.61
0.74
ug/l
0.66
19
223
28
350
0.76
0.62
3.9
3.2
—
—
—
0
0
22
167
1.36
0.60
2.1
2.2
2.40
2.33
g/l
0.20
22
153
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
65
571
1.22
0.59
1.9
1.9
92.59
94.45
pmol/l
0.11
31
291
104
959
1.22
0.58
5.1
3.6
14.83
14.87
pmol/l
0.05
95
854
11
73
1.54
0.57
1.8
1.4
0.69
1.09
g/l
2.16
11
68
37
441
0.79
0.57
2.6
3.2
1516.58
206.56
mg/l
0.40
26
287
140
1458
0.77
0.56
33.0
18.2
38.63
40.71
%
2.89
129
1349
33
272
1.26
0.52
1.9
1.7
0.86
1.15
mg/l
0.67
25
220
137
1305
1.26
0.52
23.2
12.4
25.82
23.23
mg/l
0.36
132
997
93
856
1.19
0.50
4.9
4.0
—
—
—
0
0
16
120
1.37
0.48
1.1
1.3
—
—
—
0
0
19
147
1.33
0.48
13.6
6.6
2.36
1.51
mmol/l
0.44
12
122
34
287
1.23
0.45
2.9
3.4
—
—
—
0
0
8
57
1.42
0.43
1.4
1.2
—
—
—
0
0
39
448
0.83
0.42
2.7
3.1
7.44
7.63
mmol/l
0.09
31
378
47
413
1.19
0.42
6.0
4.2
—
—
—
0
0
44
385
1.19
0.41
3.5
2.9
22.65
234.95
e6/l
0.66
36
290
7
101
0.68
0.41
1.4
3.3
—
—
—
0
0
38
329
1.20
0.40
1.7
1.5
21.73
19.76
nmol/l
0.29
33
280
5
35
1.44
0.39
1.6
3.3
—
—
—
0
0
20
243
0.80
0.37
1.2
1.2
1.00
1.60
u/ml
—
7
78
6
45
1.35
0.34
2.0
1.8
—
—
—
0
0
49
443
1.15
0.31
4.8
3.4
29.36
78.58
e6/l
0.88
37
310
12
94
1.30
0.29
5.2
2.6
1.22
1.22
mmol/l
0.06
12
79
12
95
1.28
0.27
1.8
2.8
—
—
—
0
0
35
312
1.15
0.27
1.6
1.8
490.21
426.98
pmol/l
0.36
29
261
9
73
1.25
0.26
3.0
2.3
—
—
—
0
0
9
77
1.18
0.25
1.3
1.3
—
30.33
—
0
6
5
37
1.36
0.23
1.8
1.2
16.90
38.66
mg/l
—
5
28
5
37
1.36
0.23
1.8
1.2
20.94
56.70
mg/l
—
5
28
18
153
1.20
0.23
10.0
6.0
101.94
104.67
mmol/l
1.14
18
153
5
40
1.26
0.22
1.4
1.5
—
—
—
0
0
8
101
0.78
0.22
1.9
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
310.67
—
0
12
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.9
—
463.25
—
0
8
9
113
0.79
0.20
1.6
1.4
—
—
—
0
0
9
113
0.79
0.20
1.7
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
34.50
—
0
14
0
14
0.00
0.20
0.0
1.3
—
89.95
—
0
14
137
1400
0.89
0.19
26.6
14.7
78.29
82.57
umol/l
1.27
137
1400
53
564
0.91
0.18
3.8
3.8
31.09
47.69
ng/l
0.72
43
401
8
69
1.17
0.16
1.0
1.2
242.25
223.95
u/ml
—
8
64
44
470
0.91
0.16
3.7
3.8
1.00
8.90
mg/mmol
4.17
29
299
8
72
1.12
0.16
3.0
2.9
—
—
—
0
0
37
343
1.10
0.16
3.4
2.7
0.27
0.39
e6/l
0.48
29
255
9
80
1.13
0.15
1.6
1.4
—
—
—
0
0
11
94
1.18
0.13
14.3
8.4
—
—
—
0
0
134
1363
0.92
0.13
19.3
11.9
—
—
—
0
0
25
230
1.10
0.12
2.3
1.3
2.53
2.83
g/l
0.38
19
136
107
1094
0.94
0.11
26.9
14.7
14.47
14.88
%
0.45
102
1068
10
86
1.17
0.11
3.9
3.6
—
—
—
0
0
121
1187
1.07
0.11
5.9
4.5
2.19
1.94
mu/l
1.09
115
1071
61
632
0.95
0.10
3.8
3.5
0.00
0.00
estimate
—
8
102
34
324
1.06
0.07
3.3
2.6
—
—
—
0
0
29
277
1.06
0.05
1.7
1.7
1089.18
1240.87
nmol/l
0.49
23
215
61
624
0.97
0.05
5.2
4.7
0.00
0.00
estimate
—
8
106
20
189
1.07
0.05
2.4
2.2
9.97
14.07
umol/l
2.21
20
172
10
91
1.11
0.04
10.2
3.7
—
—
—
0
0
32
316
1.02
0.00
4.1
3.9
0.00
0.00
estimate
—
8
103
62
618
1.01
0.00
3.8
3.5
0.00
0.00
estimate
-0.00
11
119
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
9.1
—
996.00
—
0
8
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.8
—
11.13
—
0
8
0
8
0.00
0.00
0.0
10.5
—
1518.63
—
0
8
5
56
0.89
0.00
4.0
1.9
472.00
419.76
ug/l
—
5
49
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
6
61
0.98
0.00
1.5
2.3
1.65
0.99
%
—
6
61
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
284.70
—
0
5
0
7
0.00
-0.00
0.0
1.3
—
1.58
—
0
7
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
2830.00
—
0
5
6
59
1.02
-0.00
1.5
2.3
0.60
0.59
%
—
6
59
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
67
0.89
-0.00
1.5
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
1.17
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_NASOPHARYNX_WIDE – Malignant neoplasm of nasopharynx, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).